Submit your research
Start your submission and get more impact for your research by publishing with us.
- Frontiers in Pharmacology
- Cardiovascular and Smooth Muscle Pharmacology
Explores the interactions between chemicals and living beings
This section explores pharmacotherapy of cardiovascular disorders and those of other smooth muscle-rich organs including functional disorders of the heart, blood vessels, kidneys, and urinary tract.
Author guidelines
Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.
Editor guidelines
Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.
Peer review
Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.
Publishing fees
Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.
Editors
See all- EO
eliot ohlstein
Drexel University School of Medicine
Philadelphia, United States
Specialty Chief Editor
Cardiovascular and Smooth Muscle Pharmacology
- AA
abdel abdel-rahman
Brody School of Medicine, East Carolina University
Greenville, United States
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
- VA
vincenzo arcoraci
Department of Clinical and Experimental Medicine, University of Messina
Messina, Italy
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
- EA
ebru arioglu inan
Ankara University
Ankara, Türkiye
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
Articles
See all (1,271)Review
Published on 02 Apr 2025
Traditional Chinese medicine compounds modulate signaling pathways to improve cardiac-related pathology
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacologydoi 10.3389/fphar.2025.1499060Original Research
Published on 02 Apr 2025
LncRNA MEG3 exacerbates diabetic cardiomyopathy via activating pyroptosis signaling pathway
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacologydoi 10.3389/fphar.2025.1538059- 103 views
Original Research
Published on 01 Apr 2025
Deciphering the causality of gut microbiota, circulating metabolites and heart failure: a mediation mendelian
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacologydoi 10.3389/fphar.2025.1531384- 116 views
Original Research
Accepted on 31 Mar 2025
Cardiac protection of wogonin in mice with pulmonary fibrosis by regulating Sirt1/ γ-H2AX pathway
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacologydoi 10.3389/fphar.2025.1551141
Research Topics
See all (105)Submission open
Exercise as a Therapeutic Strategy for Reprogramming the Immune Response in Cardiovascular Disease Progression
- Bartolo Ferraro
- Michele D'Amico
- Anca Hermenean
- Maria Consiglia Trotta
- 181 views
Submission open
Exploring Small Molecule Inhibitors in Cancer, Inflammation, and Autoimmune Disorders
- Dr Manish Kumar Jeengar
- Dr Basveshwar Gawali
- Dr. Shweta Shrivastava
- Veera Ganesh Yerra
- 904 views
Submission open
Heart Failure Induced by Non-Cardiac Therapies
- Nancy Saad
- Anthony Zulli
- 344 views
Submission open
RNA applications in cardiometabolic diseases
- Osman Ahmed
- Yasin Tayem
- Fabrizia Bonacina
- 326 views